Subscribe To
INSP / Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Content Topics
Inspire
Medical
Systems
Revolutionizing
Obstructive
Sleep
Systems
Treatment
Stock
INSP
INSP News
By Zacks Investment Research
October 31, 2023
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key more_horizontal
By Seeking Alpha
October 25, 2023
Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Today, we take a deeper look at Inspire Medical Systems, Inc., a medical device manufacturer focused on solutions for obstructive sleep apnea. Despite more_horizontal
By GlobeNewsWire
October 3, 2023
Inspire Medical Systems, Inc. to Report Third Quarter 2023 Financial Results on November 7, 2023
MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quart more_horizontal
By Zacks Investment Research
September 26, 2023
Here's Why You Should Retain Inspire Medical (INSP) Stock Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock. more_horizontal
By Seeking Alpha
August 16, 2023
Inspire Medical Systems: Excellent Execution And Reset Valuation
Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to rele more_horizontal
By Seeking Alpha
August 2, 2023
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President more_horizontal
By Zacks Investment Research
August 1, 2023
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth more_horizontal
By Zacks Investment Research
August 1, 2023
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares more_horizontal